Simon Abelson
Internal Medicine · Miami, FLNPI 1295807360
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,186 of the $44,314 with a category attached, or 90.7%. Every reported general payment came from a single manufacturer, Novartis. Reporting peaked in 2021 at $14,330 and has fallen 94.8% since, to $750 in 2024. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $714.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$44K
Across 15 payments — averaging $253,558 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$2.1M
- Eli Lilly$1.3M
- Novartis$344K
- E.r. Squibb & Sons, L.L.C.$84K
- Incyte Corporation$42K
- AbbVie$12K
What the payments were for
- Consulting fees$40,18691%
- Speaking & faculty fees$3,9009%
- Travel & lodging$2281%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 62 | $44,314 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,314 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 17 | $8,321 |
| Gabapentin | 16 | $370 |
| Levothyroxine Sodium | 23 | $314 |
| Atorvastatin Calcium | 28 | $302 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $190 |
| Rosuvastatin Calcium | 27 | $182 |
| Alprazolam | 32 | $170 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $161 |
| Losartan Potassium | 16 | $158 |
| Amlodipine Besylate | 21 | $144 |
| Lisinopril | 12 | $132 |
| Metoprolol Succinate | 17 | $128 |
| Meclizine Hcl | 13 | $116 |
| Tramadol Hcl | 11 | $100 |
| Diazepam | 18 | $59 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Miami
- Haytham ElgammalMiami$2.2M
- Richard AguilarMiami$239K
- Maria Delgado LelievreMiami$80K
- Marlow HernandezMiami$58K
- Steven CohnMiami$47K
- Joseph PiperatoMiami$45K
- Joel Brooks TamayoMiami$42K
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.